Alemtuzumab induction in kidney transplant recipients

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Nephrology | 2007年 / 3卷 / 9期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：471 / 471
相关论文
共 50 条
  • [21] Alemtuzumab Induction Is Associated With an Equalization of Outcomes Between White and African American Kidney Transplant Recipients
    Brooks, Joseph T.
    Mitro, Graham
    DeLeonibus, Anthony
    Qu, Weikai
    Rees, Michael
    Nazzal, Munier
    Ortiz, Jorge
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2019, 17 (02) : 196 - 201
  • [22] Alemtuzumab versus Antithymocyte Globulin Induction Immunosuppression in Highly Sensitized Kidney Transplant Recipients.
    Brueckner, A.
    Yanqui, E.
    Truong, C.
    Baliga, R.
    Bowman, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 823 - 823
  • [23] Incidence of Viral Infections in Kidney Transplant Recipients with Alemtuzumab or Rabbit Antithymocyte Globulin Induction.
    Brueckner, A.
    Truong, C.
    Yanqui, E.
    Baliga, R.
    Bowman, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 834 - 834
  • [24] Alemtuzumab vs Thymoglobulin Induction in Highly Sensitized, Kidney Re-Transplant Recipients.
    Shaffer, David
    Truscott, Christy L.
    Tseng, Christine Y.
    Schaefer, Heidi M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 677 - 677
  • [25] ALEMTUZUMAB INDUCTION VERSUS STANDARD IMMUNOSUPPRESSION IN HEART TRANSPLANT RECIPIENTS
    Gale, Stormi
    Ravichandran, Bharath
    Ivaturi, Vijay
    Ton, Van-Khue
    Reed, Brent
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 680 - 680
  • [26] Alemtuzumab Induction Versus Conventional Immunosuppression in Heart Transplant Recipients
    Gale, Stormi E.
    Ravichandran, Bharath
    Van-Khue Ton
    Si Pham
    Reed, Brent N.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2019, 24 (05) : 435 - 441
  • [27] Alemtuzumab induction versus conventional immunosuppression in heart transplant recipients
    Leelathanalerk, Areerut
    Ingviya, Thammasin
    Ivaturi, Vijay
    Reed, Brent N.
    PHARMACOTHERAPY, 2015, 35 (11): : E292 - E293
  • [28] Kidney transplant outcomes with alemtuzumab and thymoglobulin induction.
    Bunnapradist, Suphamai
    Gill, Jagbir
    Takemoto, Steven
    Shah, Tariq
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 215 - 215
  • [29] INFLAMMATORY NEUROPATHY AFTER ALEMTUZUMAB THERAPY IN KIDNEY TRANSPLANT RECIPIENTS
    van der Zwan, Marieke
    Hesselink, Dennis A.
    Brusse, Esther
    van Doorn, Pieter A.
    van den Hoogen, Martijn W. F.
    de Weerd, Annelies E.
    Jacobs, Bart C.
    TRANSPLANTATION, 2020, 104 (09) : S382 - S382
  • [30] Immune-Mediated Injury in Kidney Transplant Recipients Treated With Alemtuzumab Induction and a Steroid Avoidance Protocol
    Sapir-Pichhadze, R.
    Mahbub, T.
    Saw, C.
    Baran, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
12345